Bioengineered Protein Drugs Market Size To Cross USD 672.7 Billion By 2034, Growing At A CAGR Of 6.2% - Report By Transparency Market Research, Inc.
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...
Diamyd Medical AB (publ): Diamyd Medical advances AI-powered screening for Type 1 Diabetes within the ASSET Project
Diamyd Medical, in collaboration with Mainly AI and ASSET partners, highlights meaningful progress in AI-driven screening and risk prediction for Type 1 Diabetes at the Advanced Technologies & Treatme ...
The Manila Times17h
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...
The Pharma Letter10h
Gene therapy for Parkinson’s at heart of new AI collab
MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...
Verona Pharma: Great Year For Share Price, But Competition Threatens Bull Thesis
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
MarketWatch15h
E-Mini Nasdaq 100 Index Continuous Contract
2-Year U.S. Treasury Note Continuous Contract $103.551 0.086 0.08% 5-Year U.S. Treasury Note Continuous Contract $107.930 0.203 0.19% 10-Year U.S. Treasury Note Continuous Contract $110.922 0.281 ...
CNN23h
Pre-markets
We read all day so you don't have to. Sign up for CNN Business' newsletter for the top stories you need to know.